Skip to main content
. Author manuscript; available in PMC: 2024 Feb 16.
Published in final edited form as: Leuk Lymphoma. 2023 Sep 6;64(13):2202–2207. doi: 10.1080/10428194.2023.2254435

Table 1.

Characteristics and outcomes of low-dose RT for CTCL.

Characteristic or outcome N (%)

Total 73
Age
 Mean age ± SD 63 ± 14
 Range 40–89
Gender
 Female 11 (15%)
 Male 62 (85%)
Race
 Black or African American 25 (34.2%)
 White or Caucasian 47 (64.4%)
 other 1 (1.4%)
Lesion type
 TL 25 (34.2%)
 Non-TL 48 (65.7%)
Location of lesion
 Head/neck 12 (16%)
 Chest, abdomen, or trunk 14 (19%)
 Upper extremity 22 (30%)
 Lower extremity 25 (34%)
Large cell transformation?
 Yes 5 (7%)
 No 66 (93%)
Response TL Non-TL

 CR 1 (4%) 8 (17%)
 PR 20 (80%) 39 (81%)
 NR 4 (16%) 1 (2%)
 OR 21 (84%) 47 (98%)